My Tracker
My Profile
My Connections
My Settings
Send Message
Create a free account to unlock these features!

Miles D White
Track
 
Chairman of the Board and Chief Executive Officer: Abbott Laboratories
 
 Overview   News   Insider Trades   Compensation   Associated People   Investments    
Vitals
Name: Miles D White
Industries: Telecom | Healthcare | Food, Drink and Tobacco
2008 Compensation: $28,335,494
Roles:
Chairman of the Board and Chief Executive Officer: Abbott Laboratories
Board Member: Motorola,Inc. | McDonald's Corporation
Lists:
#36 Highest Compensated Executives (2006)
#29 Highest Compensated Executives (2007)
#23 Highest Compensated Executives (2008)
#28 Highest Salaries (2006)
#43 Highest Salaries (2007)
#39 Highest Salaries (2008)
All News - 1000's of sources
loading news
 new tracked items.
Tracker changed. Refresh? yes | no
Sources
 
 
check at least one:
 
 
 
 
  
1810063 8/27/10:
Can China remain the low-cost leader for long?
read entire story in a new window
Big Pharma has been stampeding into China, aiming not only to capture a share of that fast-growing drug market, but also to supply themselves with APIs and lower their manufacturing costs, either directly or via outsourcing. After all, labor is cheaper and overhead costs are lower in China. But what ... - read more at Fierce HealthCare
tags: A.T. Kearney 
1733397 8/10/10:
Abbott CEO says diversification delivers
read entire story in a new window
Miles White (photo) has been CEO of Abbott Laboratories (NYSE: ABT) for 12 years, longer than any other current Big Pharma chief. And over those 12 years, he's done well by investors; the stock is up from $34 to around $50. How did he do it, and how does he plan to keep the momentum going, now that ... - read more at Fierce HealthCare
tags: Abbott  Chattem  Pfizer  Investors Business Daily  Genentech  Sanofi-Aventis 
1729338 8/9/10:
Cramer: Six Stocks With Highest Comeback Potential
read entire story in a new window
In an article on CNBC, the host of Mad Money pulled out many stocks from the worst-performing sectors of the S&P 500. He believes that these stocks offer a tremendous amount of potential to make a back. While one of them has lost more than half of its value, the losses suffered by others have not ... - read more at Benzinga
tags: Abbott Labs (NYSE: ABT)  AK Steel Holdings (NYSE: AKS)  Jabil Circuit (NYSE: JBL)  NVIDIA (NASDAQ: NVDA)  Range Resources (NYSE: RRC)  Verizon Communications (NYSE: VZ) 
1722793 8/6/10:
Abbott Labs CEO Says He Walks A Tightrope
read entire story in a new window
Every year for 38 years, Abbott Laboratories has paid shareholders a dividend greater than that paid the year before. It's part of the company's "investment image," said Chief Executive Miles White in an interview with IBD. To build future dividends, Abbott (ABT) will expand its overseas business, he ... - read more at Investor's Business Daily
tags: Abbott Labs  Healthcare Solutions 
1663468 7/27/10:
Abbott Labs - Growth & Income
read entire story in a new window
Abbott Labs' (ABT) diverse businesses enable the company to deliver a steady stream of revenue and earnings. Growth and Income The company is expected to grow its earnings per share 11.3% in 2010, 11.4% in 2011, and 10.6% over the long term. Its trailing 12-month return on equity is 28.2%. The stock ... - read more at Zacks - Growth and Income
tags: Abbott Labs 
1585845 7/7/10:
Top 10 Pharma CEO salaries of 2009
read entire story in a new window
Welcome to to our annual look at the biggst CEO paychecks in the pharma industry. The major trend in 2009 was the mega-merger, which helped propel former Schering-Plough CEO Fred Hassan to the top of this year's list. With the help of a $33 million golden handshake, Hassan bypassed perennial top dogs ... - read more at Fierce HealthCare
tags: Johnson & Johnson  Schering-Plough  Novartis  Daniel Vasella  CEO Fred Hassan  Bill Weldon  Joe Jimenez 
1390891 5/21/10:
Abbott captures Piramal with $3.7B deal
read entire story in a new window
Abbott Laboratories (NYSE: ABT) just leapfrogged its way to No. 1 in India's drug market. The U.S.-based company agreed to buy the domestic unit of Piramal Healthcare, one of India's big generics makers, for $3.7 billion. A Piramal deal has been in play for some time, with Big Pharma companies such ... - read more at Fierce HealthCare
tags: Abbott  Merck  Pfizer (NYSE: PFE)  Daiichi Sankyo  Financial Times  Sanofi-Aventis (NYSE: SNY)  Dow Jones 
1389839 5/21/10:
Abbott to acquire Piramal business for $3.7 bln
read entire story in a new window
LONDON (MarketWatch) -- Abbott Laboratories said Friday that it's agreed to buy the healthcare solutions division of Piramal Healthcare for a total of around $3.7 billion. Abbott said it will make an upfront payment of $2.12 billion for the business, which is a leader in the branded generics market ... - read more at Market Watch
tags: Abbott  MarketWatch.com 
see more news »
 Miles D White Insider Ownership:*
  Ticker Name Price Change
ABT Abbott Laboratories 50.49 -0.25 (-0.49%)
ABT intra-day stock price chart:
Miles D White ABT ownerships:
# shares Nature of ownership Last reported
1,272,309 direct 2010-03-10 00:00:00
5,955 indirect - By son 2009-12-08 00:00:00
4,755 indirect - By wife for son 2006-12-20 00:00:00
MCD McDonald's Corporation 75.80 +0.71 (+0.95%)
MCD intra-day stock price chart:
Miles D White MCD ownerships:
# shares Nature of ownership Last reported
5,000 direct 2009-05-14 00:00:00
MOT Motorola,Inc. 7.83 -0.11 (-1.39%)
MOT intra-day stock price chart:
Miles D White MOT ownerships:
# shares Nature of ownership Last reported
60,348 direct 2009-04-01 00:00:00
* Miles D White reported owning these shares as an insider for all or part of the last 18 months. (See What is an 'insider'? for more details.)
see more »
Latest Miles D White Trades:
Mar 10, 2010: SOLD 70,700 ABT shares [SEC Filing]
Feb 26, 2010: SOLD 66,410 ABT shares [SEC Filing]
Feb 19, 2010: BOUGHT 200,000 ABT shares [SEC Filing]
Feb 18, 2010: SOLD 29,300 ABT shares [SEC Filing]
Dec 22, 2009: BOUGHT 172,704 ABT shares [SEC Filing]
Dec 22, 2009: SOLD 172,704 ABT shares [SEC Filing]
Dec 8, 2009: BOUGHT 221 ABT shares [SEC Filing]
Dec 8, 2009: SOLD 221 ABT shares [SEC Filing]
Dec 5, 2009: BOUGHT 239 ABT shares [SEC Filing]
Dec 5, 2009: SOLD 239 ABT shares [SEC Filing]
Dec 4, 2009: BOUGHT 460 ABT shares [SEC Filing]
Dec 4, 2009: BOUGHT 717 ABT shares [SEC Filing]
Dec 4, 2009: SOLD 21,577 ABT shares [SEC Filing]
Dec 4, 2009: SOLD 478 ABT shares [SEC Filing]
Oct 1, 2009: SOLD 2,041 ABT shares [SEC Filing]
see more trades »
© 2010 Tracked.com. All Rights Reserved.   About Us   |  Tour   |  Jobs   |  Contact Us   |  Terms of Use   |  Privacy Policy   |  Tracked.com Insights